Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqCM - Delayed Quote USD

Allarity Therapeutics, Inc. (ALLR)

Compare
0.8836
-0.0265
(-2.91%)
At close: April 2 at 4:00:01 PM EDT
0.8700
-0.01
(-1.54%)
Pre-Market: 4:24:45 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
15,100
17,129
16,892
26,556
8,319
Operating Income
-15,100
-17,129
-16,892
-26,556
-8,319
Net Non Operating Interest Income Expense
-491
-476
-193
-1,987
-320
Other Income Expense
-3,491
5,787
-494
2,028
2,220
Pretax Income
-19,082
-11,818
-17,579
-26,515
-6,419
Tax Provision
-298
83
-1,521
133
198
Net Income Common Stockholders
-19,423
-20,416
-21,051
-26,648
-6,602
Diluted NI Available to Com Stockholders
-19,423
-20,416
-21,051
-26,648
-6,602
Basic EPS
5.45k
-6.16k
-31.80k
-79.07k
-19.65k
Diluted EPS
5.45k
-6.16k
-31.80k
-79.07k
-19.65k
Basic Average Shares
526.2700
3.3170
0.6620
0.3370
0.3360
Diluted Average Shares
526.2700
3.3170
0.6620
0.3370
0.3360
Total Operating Income as Reported
-24,803
-17,129
-34,463
-26,556
-8,319
Total Expenses
15,100
17,129
16,892
26,556
8,319
Net Income from Continuing & Discontinued Operation
-18,784
-11,901
-16,058
-26,648
-6,602
Normalized Income
-15,929.2888
-16,939.6200
-15,606.7427
-28,474.4600
-8,640.8900
Interest Income
317
22
30
--
--
Interest Expense
808
498
223
640
320
Net Interest Income
-491
-476
-193
-1,987
-320
EBIT
-18,274
-11,320
-17,356
-25,875
-6,099
EBITDA
-18,257
-11,283
-17,296
-25,769
-6,053
Reconciled Depreciation
17
37
60
106
46
Net Income from Continuing Operation Net Minority Interest
-18,784
-11,901
-16,058
-26,648
-6,602
Total Unusual Items Excluding Goodwill
-2,900
6,378
-494
2,502
2,793
Total Unusual Items
-2,900
6,378
-494
2,502
2,793
Normalized EBITDA
-15,357
-17,661
-16,802
-28,271
-8,846
Tax Rate for Calcs
0
0.0002
0.0001
0.0003
0.0003
Tax Effect of Unusual Items
-45.2888
1,339.3800
-42.7427
675.5400
754.1100
12/31/2020 - 12/21/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

RNAZ TransCode Therapeutics, Inc.
0.5285
-2.29%
 
GNPX Genprex, Inc.
0.2950
+28.21%
 
DRMA Dermata Therapeutics, Inc.
0.9900
-0.97%
 
QNRX Quoin Pharmaceuticals, Ltd.
0.2925
+37.52%
 
CDT Conduit Pharmaceuticals Inc.
0.7469
+3.43%
 
HEPA Hepion Pharmaceuticals, Inc.
0.4780
-1.44%
 
SNSE Sensei Biotherapeutics, Inc.
0.3660
+5.84%
 
ONCO Onconetix, Inc.
0.0793
+4.76%
 
VRPX Virpax Pharmaceuticals, Inc.
1.2200
-4.69%
 
ADTX Aditxt, Inc.
5.0000
+10.62%